BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu QF, Li Y, Zhao QH, Wang ZY, Hu S, Yang CQ, Ye K, Li L. Association of STAT4 rs7574865 polymorphism with susceptibility to inflammatory bowel disease: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2015;39:627-636. [PMID: 26066297 DOI: 10.1016/j.clinre.2015.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Dąbrowska-Żamojcin E, Dziedziejko V, Safranow K, Domański L, Słuczanowska-Głabowska S, Pawlik A. STAT4 gene polymorphism in patients after renal allograft transplantation. Cent Eur J Immunol 2016;41:255-9. [PMID: 27833442 DOI: 10.5114/ceji.2016.63124] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Mizoguchi A, Takeuchi T, Himuro H, Okada T, Mizoguchi E. Genetically engineered mouse models for studying inflammatory bowel disease. J Pathol. 2016;238:205-219. [PMID: 26387641 DOI: 10.1002/path.4640] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
3 Wu S, Wang M, Wang Y, Zhang M, He JQ. Polymorphisms in the STAT4 gene and tuberculosis susceptibility in a Chinese Han population. Microb Pathog 2019;128:288-93. [PMID: 30660736 DOI: 10.1016/j.micpath.2019.01.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Wu S, Wang M, Wang Y, Zhang M, He JQ. Polymorphisms of the STAT4 gene in the pathogenesis of tuberculosis. Biosci Rep 2018;38:BSR20180498. [PMID: 30054428 DOI: 10.1042/BSR20180498] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Goswami R, Kaplan M. STAT Transcription Factors in T Cell Control of Health and Disease. Elsevier; 2017. pp. 123-80. [DOI: 10.1016/bs.ircmb.2016.09.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
6 Abdel-Wahab N, Diab A, Yu RK, Futreal A, Criswell LA, Tayar JH, Dadu R, Shannon V, Shete SS, Suarez-Almazor ME. Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors. Cancer Immunol Immunother 2021;70:1939-49. [PMID: 33409738 DOI: 10.1007/s00262-020-02797-0] [Reference Citation Analysis]
7 Zundler S, Neurath MF. Integrating Immunologic Signaling Networks: The JAK/STAT Pathway in Colitis and Colitis-Associated Cancer. Vaccines (Basel). 2016;4:5. [PMID: 26938566 DOI: 10.3390/vaccines4010005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
8 Chen E, Chen C, Chen F, Yu P, Lin L. Positive association between MIC gene polymorphism and tuberculosis in Chinese population. Immunol Lett 2019;213:62-9. [PMID: 31400356 DOI: 10.1016/j.imlet.2019.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Chaimowitz NS, Forbes LR. Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling. Current Opinion in Pediatrics 2019;31:843-50. [DOI: 10.1097/mop.0000000000000841] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Cordes F, Foell D, Ding JN, Varga G, Bettenworth D. Differential regulation of JAK/STAT-signaling in patients with ulcerative colitis and Crohn’s disease. World J Gastroenterol 2020; 26(28): 4055-4075 [PMID: 32821070 DOI: 10.3748/wjg.v26.i28.4055] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]